Medopad provides better healthcare using AI

Customized solutions to successfully treat the most challenging environmental issues

Dentavations provided a water carries removal system

Neonatal Rescue provides a ventilator device to help newborn babies breathe

After winning a social innovation competition through Brigham Young University (BYU) Marriott School, the university' spinoff Neonatal Rescue is poised to introduce its newborn ventilator machine to the developing world to save babies' lives. The NeoLife Ventilator is a new, innovative piece of medical equipment for newborn babies. The device offers the same CPAP technology used to treat and resuscitate babies in hospitals in the U.S., but at a fraction of the cost. Potentially, this machine can save millions of lives throughout the world and help third world countries improve the outcome of newborns.

by
70 days ago

EMR and billing software for PTs and OTs

Clinicient, Inc. provides software-enabled revenue cycle management solutions for outpatient rehabilitation clinics. The company offers physical therapy software that provides patient scheduling, clinical documentation, revenue management, and management reporting services, as well as practice management software and physical therapy billing services. Clinicient's vision is to improve 20 million lives by 2025. This is their higher purpose and what drives them to help therapists and clinics thrive in all aspects of their business. Their true single system for EMR and billing brings everything together in one place to run and grow a thriving patient-centric practice.

by
72 days ago

Products that optimize enteral feeding and prevent aspiration pneumonia

A device for monitoring patients on a respirator and patients fed through tubes has been developed by Israeli spinoff company, ART Medical. It offers products that optimize enteral feeding as well as detect and prevent aspiration pneumonia (lat. Pneumoniae), VAP, and kidney. Tube-related reflux and secretion may cause aspiration pneumonia (AP) and ventilator-associated pneumonia (VAP). Both are dangerous complications unrelated to the original reason for hospitalization in the intensive care unit (ICU). These complications result in prolonged lengths of stay and higher risk of mortality. In order to minimize the risk, gastric reflux and saliva must be identified in real-time and treated immediately. 

by
72 days ago

CellScope provides smarter family care

CardioCube voice-based AI system can manage your heart disease

Biomarker.io provides the engine that drives truly personalized health and wellness

Diabetic biomarker test

The newly introduced Glycated Serum Protein (GSP) LiquiColor® diabetic (lat. Diabetes Mellitus) biomarker test, developed by EKF Diagnostics, has been verified for use on the Siemens Vista chemistry analyzer. EKF Diagnostics is a medical manufacturer of Point-of-Care (POC) and Central Laboratory technology including tests for hemoglobin, HbA1c, glucose, lactate and a range of chemistry reagents. Their products have a hard-earned reputation for ease of use, reliability and accuracy. Their POC blood analyzers are simple to use and designed to quickly deliver accurate results to aid the diagnosis of anemia, diabetes and associated conditions. EKF products are used in more than 100 countries by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, sports medicine, Emergency Rooms and laboratories.

by
79 days ago

Novel biomarker test predicts high-grade prostate cancer

ProteoMediX AG presented results from a retrospective study that showed the correlation of its prostate cancer diagnostic test with cancer (lat. Carcinoma) aggressiveness in patients scheduled for prostate biopsies. The study findings presented at the 2018 European Association of Urology (EAU) congress in Copenhagen, Denmark showed that the test has the potential to avoid a large number of biopsies. ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof. The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard. This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

by
79 days ago

Cardiologs - the first ECG solution powered by AI

Ambulatory ECG analysis and reporting is a labor-intensive process, resulting in important costs and delays for arrhythmia detection. By applying the latest research in Artificial intelligence and digital biomarkers, Cardiologs provides a web solution to streamline this process at a large scale, enabling the highest diagnostic yield, for the least physician effort. Currently, FDA cleared and CE marked, Cardiologs can read ECG recordings from any digital device. Take an ECG signal, upload it to the Cardiologs cloud and get to the report in a few clicks.

by
82 days ago

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.

I AGREE

SPINOFF.COM HELPS YOU WITH:

100% Free of Cost For Scientists:

  • One hour of USA/EU attorney consulting
  • 24/7 support of 24 in-house professionals
  • 10 GB space for every scientist (own German Servers)
  • Syndicates with the leading professionals
  • 2,000 000 views of top spinoff are guaranteed
  • The largest DB of professional Investors - over 30.000

100% Free of Cost For Investors:

  • Investment information on 8,000+ spinoffs per year
  • All documents in one place (after NDA)
  • Testimonials from Key Opinion Leaders
  • AI-SDB hides irrelevant spinoffs - saved time up to 90% 
  • One-Click-Reports (OCRs) in own tailored design (PDF)

100% Free of Cost For Universities:

  • Professional Science Spinoff University Report (PDF)
  • No Links to Spinoff.com - Ready to Print and Share
  • Professional dossiers on over 27Tsd VC/PE/FO/ML
  • Professional dossiers on over 3Tsd MNC